Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 15, 2025 | May 16, 2025 |
| Huron Consulting Group Inc.HURN · Entity 4332 | Director | April 01, 2020 | April 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,575 |
Ending reported balance
After 2025-05-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-05-15 · Sale · Disposed 35 · Balance 5,680 F1: This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. Row 2 · 2025-05-15 · Sale · Disposed 81 · Balance 5,599 F2: This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. Row 3 · 2025-05-15 · Sale · Disposed 24 · Balance 5,575 F3: This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
F2: This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
F3: This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Huron Consulting Group Inc.
Report date April 01, 2020 · Filed April 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,719 |
Reported balance
After 2020-04-01 transaction · row 1
1 source rowRow 1 · 2020-04-01 · Sale · Disposed 760 · Balance 17,719 F1: Automatic sale pursuant to a 10b5-1 plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Automatic sale pursuant to a 10b5-1 plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2020 Filed May 12, 2020 17:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 741 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016227 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,825 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 15:51 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 760 | $43.56 | $33,105.60 |
DisclosureSEC source: 0001567619-20-007493 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,719 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 17:39 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 760 | $68.70 | $52,212.00 |
DisclosureSEC source: 0001567619-20-000466 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,479 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 15:11 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-022706 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,239 F1 · kind: Mr. Massaro gifted shares to The Fidelity Charitable Gift Fund, a donor advised fund. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 19:38 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 760 | $61.35 | $46,626.00 |
DisclosureSEC source: 0001567619-19-019206 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,239 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:56 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 547 | $50.02 | $27,360.94 |
DisclosureSEC source: 0001567619-19-014302 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,999 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.91 to $50.13. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:29 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019570 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,084 F1 · kind: Consists of 1,882 unvested restricted stock units that vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.86 | $13,186.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 12 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,202 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 31 | $131.66 | $4,081.46 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 11 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,302 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.61 | $13,161.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 10 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,333 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.55 | $13,155.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 9 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,433 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.53 | $13,153.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 8 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,533 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 71 | $131.52 | $9,337.92 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 7 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,633 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.45 | $13,145.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 6 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,704 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.18 | $13,118.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 5 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,804 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.17 | $13,117.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 4 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,904 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $131.16 | $13,116.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 3 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,004 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $130.73 | $13,073.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 2 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,104 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 15, 2019 Filed May 16, 2019 14:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-018632 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,204 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,140 | $0.00 Strike: $70.29 | $0.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · derivative · entry 29 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,140 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $136.53 | $13,653.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 28 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,204 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $136.35 | $13,635.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 27 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,304 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $136.00 | $13,600.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 26 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,404 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $135.62 | $27,124.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 25 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,504 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $135.60 | $13,560.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 24 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,704 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $135.05 | $27,010.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 23 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,804 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 59 | $134.98 | $7,963.82 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 22 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,004 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $134.97 | $13,497.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 21 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,063 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 141 | $134.96 | $19,029.36 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 20 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,163 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $134.89 | $13,489.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 19 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,304 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $134.77 | $26,954.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 18 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,404 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $134.73 | $26,946.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 17 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,604 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $134.59 | $13,459.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 16 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,804 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $134.54 | $26,908.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 15 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,904 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $134.53 | $40,359.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 14 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,104 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $134.27 | $13,427.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 13 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,404 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $134.12 | $13,412.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 12 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,504 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $133.70 | $26,740.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 11 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,604 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $133.60 | $13,360.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 10 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,804 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $133.42 | $13,342.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 9 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,904 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $133.40 | $13,340.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 8 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,004 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $133.23 | $13,323.00 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 7 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,104 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $133.17 | $1,331.70 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 6 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,204 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $133.15 | $133.15 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 5 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,214 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $133.14 | $133.14 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 4 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,215 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $133.13 | $133.13 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 3 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,216 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 127 | $133.12 | $16,906.24 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 2 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,217 Read SEC document |
| May 10, 2019 Filed May 13, 2019 16:52 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,140 | $70.29 | $220,710.60 |
DisclosureSEC source: 0001127602-19-018266 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2019 Filed May 7, 2019 19:39 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | GrantCommon Stock | 3,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-009984 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,546 F1 · shares: Huron Consulting Group Inc. awarded restricted stock to reporting person. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 18:08 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 735 | $47.21 | $34,699.35 |
DisclosureSEC source: 0001567619-19-008293 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,121 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.93 to $47.56. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.